PTCT
PTC Therapeutics Inc
NASDAQ: PTCT · HEALTHCARE · BIOTECHNOLOGY
$65.06
+0.79% today
Updated 2026-04-30
Market cap
$5.83B
P/E ratio
8.19
P/S ratio
3.37x
EPS (TTM)
$8.58
Dividend yield
—
52W range
$36 – $88
Volume
1.2M
PTC Therapeutics Inc (PTCT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2004 | 2005 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | $-20.77M | $-47.93M | $-46.92M | $-57.27M | $-124.34M | $-103.57M | $-10.06M | $-27.64M | $-98.64M | $-194.07M | $-251.33M | $-356.65M | $-158.42M | $-107.69M | $711.20M |
| Capital expenditures | $1.12M | $962000.00 | $165116.00 | $188681.00 | $845732.00 | $4.66M | $2.72M | $1.78M | $3.10M | $15.53M | $45.44M | $55.98M | $85.33M | $152.46M | $120.62M | $74.25M | $8.86M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $2.82M | $2.29M | $8.43M | $19.31M | $33.98M | $35.01M | $30.56M | $33.25M | $42.13M | $70.33M | $103.51M | $110.33M | $131.21M | $74.61M | $73.74M |
| Free cash flow | — | — | $-20.93M | $-48.12M | $-47.77M | $-61.94M | $-127.06M | $-105.34M | $-13.16M | $-43.17M | $-144.08M | $-250.05M | $-336.66M | $-509.11M | $-279.04M | $-181.94M | $702.34M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $12.69M | $34.33M | $8.27M | $299000.00 | $53.47M | $57.71M | $126.03M | $-86.90M | $-11.27M | $101.48M | — | — | — |